The conduction system in cardiac amyloidosis

1977 ◽  
Vol 62 (5) ◽  
pp. 677-686 ◽  
Author(s):  
Ren L. Ridolfi ◽  
Bernadine H. Bulkley ◽  
Grover M. Hutchins
CHEST Journal ◽  
1986 ◽  
Vol 90 (4) ◽  
pp. 619-621 ◽  
Author(s):  
Alberto Volpi ◽  
Augusto Cavalli ◽  
Aldo Pietro Maggioni ◽  
Luigi Matturri ◽  
Lino Rossi

2006 ◽  
Vol 99 (12) ◽  
pp. 1390-1392 ◽  
Author(s):  
Praveen Garg ◽  
Ruchi Gupta ◽  
David H. Hsi ◽  
Lucy A. Sheils ◽  
Michael R. DiSalle ◽  
...  

2020 ◽  
Vol 128 ◽  
pp. 140-146
Author(s):  
Eoin Donnellan ◽  
Oussama M. Wazni ◽  
Walid I. Saliba ◽  
Mazen Hanna ◽  
Mohamed Kanj ◽  
...  

2018 ◽  
Author(s):  
Munish Sharma ◽  
Eduard Koman ◽  
Gary S. Ledley ◽  
Sung-Hae Cho

Amyloidosis is a complex group of disorders that can involve many organs and cause their dysfunction. Cardiac involvement indicates worse prognosis and influences treatment strategies. Cardiac amyloidosis is an under-diagnosed entity and high index of clinical suspicion and careful interpretation of basic diagnostic tools such as electrocardiogram and echocardiography is needed for early detection. Congestive heart failure due to restrictive pattern and/or conduction system abnormality, in absence of coronary artery disease should raise suspicion. We present a case of transthyretin related cardiac amyloidosis and discuss the key clinical and diagnostic findings along with review of existing literature regarding its management and outcomes.


1997 ◽  
Vol 80 (11) ◽  
pp. 1491-1492 ◽  
Author(s):  
Verghese Mathew ◽  
Lyle J Olson ◽  
Morie A Gertz ◽  
David L Hayes

Author(s):  
Konstantinos Lampropoulos ◽  
◽  
Athanasios Triantafyllou ◽  
Ioannis Kapelakis ◽  
Epameinondas Triantafyllou ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document